The switch from fetal to adult hemoglobin.
暂无分享,去创建一个
[1] R. Carpenter,et al. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention‐to‐treat , 2002, BJOG : an international journal of obstetrics and gynaecology.
[2] D. Weatherall,et al. World distribution, population genetics, and health burden of the hemoglobinopathies. , 2012, Cold Spring Harbor perspectives in medicine.
[3] S. Orkin,et al. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. , 2011, Blood.
[4] T. Chan,et al. Venous thrombosis in haemoglobin H disease after splenectomy. , 1982, Australian and New Zealand journal of medicine.
[5] D. Chui,et al. Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care Problem , 1998 .
[6] T. Townes,et al. KLF1 regulates BCL11A expression and γ- to β-globin gene switching , 2010, Nature Genetics.
[7] Yung Hang Lam,et al. Middle cerebral artery Doppler study in fetuses with homozygous α‐thalassaemia‐1 at 12–13 weeks of gestation , 2002 .
[8] E. Benz. Newborn screening for α-thalassemia--keeping up with globalization. , 2011, The New England journal of medicine.
[9] Serena Sanna,et al. Amelioration of Sardinian beta0 thalassemia by genetic modifiers. , 2009, Blood.
[10] Steve Best,et al. cMYB is involved in the regulation of fetal hemoglobin production in adults. , 2006, Blood.
[11] P. Moi,et al. Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin , 2011, Haematologica.
[12] Angela N Koehler,et al. A complex task? Direct modulation of transcription factors with small molecules. , 2010, Current opinion in chemical biology.
[13] E. Benz. Clinical management of gene expression. , 1982, The New England journal of medicine.
[14] S. Schrier,et al. The instability of the membrane skeleton in thalassemic red blood cells. , 1995, Blood.
[15] D. Persons,et al. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders. , 2009, Hematology. American Society of Hematology. Education Program.
[16] V. Lefebvre,et al. Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development. , 2006, Blood.
[17] Cameron S. Osborne,et al. The Corfu deltabeta thalassemia deletion disrupts gamma-globin gene silencing and reveals post-transcriptional regulation of HbF expression. , 2005, Blood.
[18] E. Lander,et al. MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13 , 2011, Proceedings of the National Academy of Sciences.
[19] C. Chow,et al. Outcome of intensive care of homozygous alpha‐thalassaemia without prior intra‐uterine therapy , 2007, Journal of paediatrics and child health.
[20] O. Platt,et al. Hydroxyurea for the treatment of sickle cell anemia. , 2008, The New England journal of medicine.
[21] D. Faller,et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. , 1993, The New England journal of medicine.
[22] S. Orkin,et al. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. , 1984, The Journal of clinical investigation.
[23] S. Fucharoen,et al. Hb H disease: clinical course and disease modifiers. , 2009, Hematology. American Society of Hematology. Education Program.
[24] Raymond E. Moellering,et al. Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.
[25] G. Rodgers,et al. Mortality in sickle cell disease. , 1994 .
[26] S. Okada,et al. Hb Constant Spring [α142, Term→Gln (TAA>CAA in α2)] in the α-Thalassemia of Anemic Patients in Myanmar , 2008, Hemoglobin.
[27] T. Spector,et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults , 2007, Proceedings of the National Academy of Sciences.
[28] Cong Peng,et al. Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing , 2011, Science.
[29] Daniel G. Anderson,et al. Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.
[30] T. Graeber,et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. , 2011, Genes & development.
[31] Simon Heath,et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15 , 2007, Nature Genetics.
[32] M. Groudine,et al. Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation , 1981, Nature.
[33] M L Terrin,et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.
[34] A. Kulozik,et al. SICKLE CELL DISEASE IN ORISSA STATE, INDIA , 1986, The Lancet.
[35] D. Jamison,et al. Disease Control Priorities in Developing Countries , 1993 .
[36] Stuart H. Orkin,et al. Developmental and species-divergent globin switching are driven by BCL11A , 2009, Nature.
[37] R. Liang,et al. Successful mismatched sibling cord blood transplant in Hb Bart's disease , 2001, Bone Marrow Transplantation.
[38] H. Bard,et al. Relative rates of fetal hemoglobin and adult hemoglobin synthesis in cord blood of infants of insulin-dependent diabetic mothers. , 1985, Pediatrics.
[39] M. Lathrop,et al. The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. , 2009, Blood.
[40] E. Vichinsky,et al. Newborn screening for hemoglobinopathies in California , 2009, Pediatric blood & cancer.
[41] O. Castro,et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. , 1994, Blood.
[42] S. Jane,et al. Hemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific protein. , 1995, The EMBO journal.
[43] J. D. Engel,et al. Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes , 2011, Proceedings of the National Academy of Sciences.
[44] P. Musgrove,et al. Inherited Disorders of Hemoglobin , 2006 .
[45] S. Jane,et al. Repression of human gamma-globin gene expression by a short isoform of the NF-E4 protein is associated with loss of NF-E2 and RNA polymerase II recruitment to the promoter. , 2006, Blood.
[46] T. Maniatis,et al. Molecular cloning and characterization of the human beta-like globin gene cluster. , 1980, Cell.
[47] G. Anderson,et al. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c‐Myb , 2003, The EMBO journal.
[48] J. Huhta,et al. A cardiovascular profile score in the surveillance of fetal hydrops , 2006, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[49] Jennifer G Michlitsch,et al. Recent advances in bone marrow transplantation in hemoglobinopathies. , 2008, Current molecular medicine.
[50] G. Atweh,et al. Pharmacologic induction of fetal hemoglobin production. , 2010, Hematology/oncology clinics of North America.
[51] J. Clegg,et al. Benign sickle-cell anaemia. , 1972, British journal of haematology.
[52] T. Golub,et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease , 2010, Proceedings of the National Academy of Sciences.
[53] S. Blackwell,et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. , 2000, The New England journal of medicine.
[54] Peter A. Jones,et al. Cellular differentiation, cytidine analogs and DNA methylation , 1980, Cell.
[55] B. Pace,et al. alpha-Amino butyric acid cannot reactivate the silenced gamma gene of the beta locus YAC transgenic mouse. , 1994, Blood.
[56] Y. Lau,et al. Prevalence and genotypes of α- and β-thalassemia carriers in Hong Kong : Implications for population screening , 1997 .
[57] K. McIntyre,et al. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis. , 1985, The Journal of clinical investigation.
[58] R. Young,et al. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.
[59] S. Pfister,et al. Neurodevelopmental outcome and haematological course of a long‐time survivor with homozygous alpha‐thalassaemia: Case report and review of the literature , 2005, Acta paediatrica.
[60] Farrukh T Shah,et al. Iron overload in thalassemia and related conditions: therapeutic goals and assessment of response to chelation therapies. , 2010, Hematology/oncology clinics of North America.
[61] N. Olivieri,et al. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies. , 1995, The New England journal of medicine.
[62] D. Zwiers,et al. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[63] Giancarlo Mari,et al. NONINVASIVE DIAGNOSIS BY DOPPLER ULTRASONOGRAPHY OF FETAL ANEMIA DUE TO MATERNAL RED-CELL ALLOIMMUNIZATION , 2000 .
[64] Masayuki Yamamoto,et al. Transgene Insertion in Proximity to thec-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation , 2006, Molecular and Cellular Biology.
[65] E Vichinsky,et al. Pain in sickle cell disease. Rates and risk factors. , 1991, The New England journal of medicine.
[66] TEA Peto,et al. Haemoglobin E β thalassaemia in Sri Lanka , 2005, The Lancet.
[67] M. Cappellini,et al. Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia. , 2012, Blood.
[68] Jonathan D. Powell,et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. , 2009, The New England journal of medicine.
[69] G. Lettre. The search for genetic modifiers of disease severity in the β-hemoglobinopathies. , 2012, Cold Spring Harbor perspectives in medicine.
[70] 5—Azacytidine selectively increases globin synthesis in a patient with thalassemia , 1983 .
[71] K. McGrath,et al. Ontogeny of erythropoiesis in the mammalian embryo. , 2008, Current topics in developmental biology.
[72] J. Hirschhorn,et al. Supporting Online Material Materials and Methods Figs. S1 to S10 Tables S1 to S7 References Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-specific Repressor Bcl11a , 2022 .
[73] Cameron S. Osborne,et al. The Corfu δβ thalassemia deletion disrupts γ-globin gene silencing and reveals post-transcriptional regulation of HbF expression Running title: Corfu δβ thalassemia and β-globin regulation , 2005 .
[74] V. Chan,et al. Hemoglobin H disease: not necessarily a benign disorder. , 2003, Blood.
[75] D. Weatherall. Hemoglobinopathies worldwide: present and future. , 2008, Current molecular medicine.
[76] J. D. Engel,et al. Embryonic and fetal β‐globin gene repression by the orphan nuclear receptors, TR2 and TR4 , 2007, The EMBO journal.
[77] Suthat Fucharoen,et al. The hemoglobin E thalassemias. , 2012, Cold Spring Harbor perspectives in medicine.
[78] Doppler Ultrasonography Versus Amniocentesis to Predict Fetal Anemia , 2006, The New England journal of medicine.
[79] G. Stamatoyannopoulos,et al. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics. , 1984, Science.
[80] A. Schuh,et al. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults , 2012, Haematologica.
[81] A. Taher,et al. b -Thalassemia Intermedia: A Clinical Perspective , 2012 .
[82] D. Faller,et al. Delay in the fetal globin switch in infants of diabetic mothers. , 1985, The New England journal of medicine.
[83] R. Heller,et al. Heterozygous disruption of human SOX6 is insufficient to impair erythropoiesis or silencing of fetal hemoglobin. , 2011, Blood.
[84] C. Hoppe. Newborn screening for non-sickling hemoglobinopathies. , 2009, Hematology. American Society of Hematology. Education Program.
[85] Yusuke Nakamura,et al. A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E , 2009, Human Genetics.
[86] Jérôme Larghero,et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.
[87] S. Lowe,et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.
[88] M. Sutton,et al. butyrate-mediated induction of fetal hemoglobin Role of epigenetic modifications in normal globin gene regulation and , 2013 .
[89] S. Schrier,et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. , 2000, Blood.
[90] S. Carr,et al. Intrauterine therapy for homozygous alpha-thalassemia. , 1995, Obstetrics and gynecology.
[91] Chris Fisher,et al. A functional element necessary for fetal hemoglobin silencing. , 2011, The New England journal of medicine.
[92] S. Orkin,et al. Transcriptional regulation of erythropoiesis: an affair involving multiple partners , 2002, Oncogene.
[93] G. Stamatoyannopoulos,et al. Regulation of embryonic/fetal globin genes by nuclear hormone receptors: a novel perspective on hemoglobin switching , 1999, The EMBO journal.
[94] H. Witkowska,et al. Universal newborn screening for Hb H disease in California. , 2001, Genetic testing.
[95] T. Suntharasaj,et al. Etiology and Outcome of Non-Immune Hydrops fetalis in Southern Thailand , 2005, Gynecologic and Obstetric Investigation.
[96] Dongzhi Li,et al. A Survey of Pregnancies with Hb Bart's Disease in Mainland China , 2009, Hemoglobin.
[97] V. Chan,et al. Molecular defects in Hb H hydrops fetalis , 1997, British journal of haematology.
[98] E. Vichinsky,et al. Heterogeneity of hemoglobin H disease in childhood. , 2011, The New England journal of medicine.
[99] F. Grosveld,et al. Fetal globin expression is regulated by Friend of Prmt1. , 2010, Blood.
[100] H. Ma,et al. Homozygous α‐thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases , 1985 .
[101] J. Hirschhorn,et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease , 2008, Proceedings of the National Academy of Sciences.
[102] H. Witkowska,et al. Hb H hydrops foetalis syndrome: a case report and review of literature , 2001, British journal of haematology.
[103] J. Watson,et al. THE SIGNIFICANCE OF THE PAUCITY OF SICKLE CELLS IN NEWBORN NEGRO INFANTS , 1948, The American journal of the medical sciences.
[104] T. Maniatis,et al. Molecular cloning and characterization of the human β-like globin gene cluster , 1980, Cell.
[105] W. Alexander,et al. Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[106] K. McIntyre,et al. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea. , 1984, The New England journal of medicine.
[107] E. Neufeld,et al. Hemoglobin H‐constant spring in North America: An alpha thalassemia with frequent complications , 2009, American journal of hematology.
[108] A. Carè,et al. Haemoglobin switching in human embryos: asynchrony of zeta----alpha and epsilon----gamma-globin switches in primitive and definite erythropoietic lineage. , 1985, Nature.
[109] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.
[110] A. Schechter,et al. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. , 1983, Blood.
[111] T. Ley,et al. 5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia. , 1982, The New England journal of medicine.
[112] C. Liao,et al. Prenatal Control of Hb Bart's Disease in Southern China , 2007, Hemoglobin.
[113] A. D. de Brevern,et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. , 2010, American journal of human genetics.
[114] R. Flavell,et al. DNA methylation in the human γδβ-globin locus in erythroid and nonerythroid tissues , 1980, Cell.
[115] J. B. Clegg,et al. The thalassaemia syndromes , 1965 .
[116] D. Oepkes,et al. Serial sonographic findings of four fetuses with homozygous alpha‐thalassemia‐1 from 21 weeks onwards , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[117] F. Grosveld,et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes Hereditary Persistence of Fetal Hemoglobin , 2010, Nature Genetics.
[118] C. Liao,et al. Detection of alpha-thalassemia in beta-thalassemia carriers and prevention of Hb Bart's hydrops fetalis through prenatal screening. , 2006, Haematologica.
[119] G. Fucharoen,et al. Prenatal Diagnosis of Hb Bart’s Hydrops Fetalis Caused by a Genetic Compound Heterozygosity for Two Different αo-Thalassemia Determinants , 2007, Fetal Diagnosis and Therapy.
[120] D. Faller,et al. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. , 1994, The American journal of pediatric hematology/oncology.
[121] J. D. Engel,et al. An embryonic/fetal β‐type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer , 2002, The EMBO journal.
[122] G. Stamatoyannopoulos,et al. Induction of human γ globin gene expression by histone deacetylase inhibitors , 2004 .
[123] Sivaraman Dandapani,et al. Current strategies for diversity-oriented synthesis. , 2010, Current opinion in chemical biology.
[124] E. Vichinsky,et al. Application of an expanded multiplex genotyping assay for the simultaneous detection of Hemoglobin Constant Spring and common deletional α‐thalassemia mutations , 2010, International journal of laboratory hematology.
[125] James Douglas Engel,et al. Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic β-Type Globin Promoters in Differentiated Adult Erythroid Cells , 2011, Molecular and Cellular Biology.
[126] E. Vichinsky,et al. Changing outcome of homozygous alpha-thalassemia: cautious optimism. , 2000, Journal of pediatric hematology/oncology.
[127] S. Orkin,et al. Advances in the understanding of haemoglobin switching , 2010, British journal of haematology.
[128] S. Orkin,et al. interactions and cooperation with SOX 6-globin by BCL 11 A involves long-range γ Transcriptional silencing of Material Supplemental , 2010 .
[129] R. Liang,et al. Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease , 2009, Annals of Hematology.
[130] Boris Lenhard,et al. Dynamic long‐range chromatin interactions control Myb proto‐oncogene transcription during erythroid development , 2012, The EMBO journal.
[131] S. Lipitz,et al. Outcome of severely anaemic fetuses treated by intrauterine transfusions , 2008, Archives of Disease in Childhood Fetal and Neonatal Edition.
[132] V. Sankaran,et al. Reversing the hemoglobin switch. , 2010, The New England journal of medicine.
[133] Gonçalo R. Abecasis,et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia , 2008, Proceedings of the National Academy of Sciences.
[134] E. Lander,et al. The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.
[135] K. Moise. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. , 2008, American journal of obstetrics and gynecology.
[136] F. Barton,et al. Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. , 1995, Controlled clinical trials.
[137] P. Kingsley,et al. A transient definitive erythroid lineage with unique regulation of the β-globin locus in the mammalian embryo. , 2011, Blood.
[138] D. Lavelle,et al. siDNMT1 increases γ-globin expression in chemical inducer of dimerization (CID)-dependent mouse βYAC bone marrow cells and in baboon erythroid progenitor cell cultures. , 2011, Experimental hematology.
[139] K. Chin,et al. SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII. , 2009, Blood.
[140] V. Chan,et al. Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease , 2006, British journal of haematology.
[141] C. Pegelow,et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. , 2003, JAMA.
[142] D. J. Weatherall,et al. Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias , 2001, Nature Reviews Genetics.
[143] F. Hecht,et al. DEVELOPMENTAL HEMOGLOBIN ANOMALIES IN A CHROMOSOMAL TRIPLICATION: D1 TRISOMY SYNDROME. , 1964, Proceedings of the National Academy of Sciences of the United States of America.
[144] J. Howard,et al. Pain in Sickle Cell Disease , 2015 .
[145] Mark A. Hall,et al. The Role of p22 NF-E4 in Human Globin Gene Switching* , 2004, Journal of Biological Chemistry.
[146] D. Higgs,et al. Genetic complexity in sickle cell disease , 2008, Proceedings of the National Academy of Sciences.
[147] M. Grosso,et al. Molecular Basis of Thalassemia , 2012 .
[148] V. Sankaran,et al. Thalassemia: an overview of 50 years of clinical research. , 2010, Hematology/oncology clinics of North America.
[149] H. Vogel,et al. Vascular‐type disruptive defects in fetuses with homozygous α‐thalassemia: report of two cases and review of the literature , 2005, Prenatal diagnosis.
[150] V. Sankaran,et al. Persistence of fetal hemoglobin expression in an older child with trisomy 13. , 2012, The Journal of pediatrics.
[151] Joel N Hirschhorn,et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation , 2010, Nature Genetics.